• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小檗碱通过抑制低氧诱导因子-2α降低高脂饮食喂养小鼠的肝脏神经酰胺水平,以改善胰岛素抵抗。

Berberine reduces hepatic ceramide levels to improve insulin resistance in HFD-fed mice by inhibiting HIF-2α.

作者信息

Xia Qing-Song, Wu Fan, Wu Wen-Bin, Dong Hui, Huang Zhao-Yi, Xu Lijun, Lu Fu-Er, Gong Jing

机构信息

Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.

Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.

出版信息

Biomed Pharmacother. 2022 Jun;150:112955. doi: 10.1016/j.biopha.2022.112955. Epub 2022 Apr 13.

DOI:10.1016/j.biopha.2022.112955
PMID:35429745
Abstract

Several studies have documented the effects of hypoxia and ceramides on lipid and glucose metabolism, resulting in insulin resistance. However, the roles of ceramide in hepatic hypoxia and hepatic insulin resistance remain to be clarified. This study aimed to explore the relationship between hypoxia, ceramide synthesis, and hepatic insulin resistance in high-fat diet (HFD)-fed mice. Given the interaction of hypoxia-inducible factors 2α(HIF-2α) and berberine determined using molecular docking, this study also assessed the pharmacological effects of berberine on the HIF-2α-ceramide-insulin resistance pathway. In the preliminary phase of the study, gradually aggravated hepatic hypoxia and varying levels of ceramides were observed with the development of type 2 diabetes mellitus (T2DM) due to increasing HIF-2α accumulation. Lipidomic analyses of animal and cell models revealed that berberine reduced hypoxia-induced ceramide production and attenuated ceramide-induced insulin resistance. This research provides timely and necessary evidence for the role of ceramide in hypoxia and insulin resistance in the liver. It also contributes to a better understanding of the pharmacological effects of berberine on ameliorating hypoxia and insulin resistance in T2DM therapy.

摘要

多项研究记录了缺氧和神经酰胺对脂质和葡萄糖代谢的影响,从而导致胰岛素抵抗。然而,神经酰胺在肝脏缺氧和肝脏胰岛素抵抗中的作用仍有待阐明。本研究旨在探讨高脂饮食(HFD)喂养的小鼠中缺氧、神经酰胺合成与肝脏胰岛素抵抗之间的关系。鉴于通过分子对接确定的缺氧诱导因子2α(HIF-2α)与小檗碱之间的相互作用,本研究还评估了小檗碱对HIF-2α-神经酰胺-胰岛素抵抗途径的药理作用。在研究的初步阶段,随着2型糖尿病(T2DM)的发展,由于HIF-2α积累增加,观察到肝脏缺氧逐渐加重以及神经酰胺水平各异。对动物和细胞模型的脂质组学分析表明,小檗碱可减少缺氧诱导的神经酰胺生成,并减轻神经酰胺诱导的胰岛素抵抗。本研究为神经酰胺在肝脏缺氧和胰岛素抵抗中的作用提供了及时且必要的证据。它也有助于更好地理解小檗碱在改善T2DM治疗中的缺氧和胰岛素抵抗方面的药理作用。

相似文献

1
Berberine reduces hepatic ceramide levels to improve insulin resistance in HFD-fed mice by inhibiting HIF-2α.小檗碱通过抑制低氧诱导因子-2α降低高脂饮食喂养小鼠的肝脏神经酰胺水平,以改善胰岛素抵抗。
Biomed Pharmacother. 2022 Jun;150:112955. doi: 10.1016/j.biopha.2022.112955. Epub 2022 Apr 13.
2
New role for ceramide in hypoxia and insulin resistance.神经酰胺在低氧和胰岛素抵抗中的新作用。
World J Gastroenterol. 2020 May 14;26(18):2177-2186. doi: 10.3748/wjg.v26.i18.2177.
3
Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2α.氧疗通过抑制低氧诱导因子-2α缓解肝脂肪变性。
J Endocrinol. 2020 Jul;246(1):57-67. doi: 10.1530/JOE-19-0555.
4
Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis.肥胖期间肠道缺氧诱导因子2α的激活会导致肝脂肪变性。
Nat Med. 2017 Nov;23(11):1298-1308. doi: 10.1038/nm.4412. Epub 2017 Oct 9.
5
Adipocyte Hypoxia-Inducible Factor 2α Suppresses Atherosclerosis by Promoting Adipose Ceramide Catabolism.脂肪细胞缺氧诱导因子 2α 通过促进脂肪神经酰胺代谢来抑制动脉粥样硬化。
Cell Metab. 2019 Nov 5;30(5):937-951.e5. doi: 10.1016/j.cmet.2019.09.016. Epub 2019 Oct 24.
6
Macrophage HIF-2α ameliorates adipose tissue inflammation and insulin resistance in obesity.巨噬细胞缺氧诱导因子-2α可改善肥胖症中的脂肪组织炎症和胰岛素抵抗。
Diabetes. 2014 Oct;63(10):3359-71. doi: 10.2337/db13-1965. Epub 2014 Jun 19.
7
Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.通过 Phd3 实现的低氧与胰岛素信号转导的串扰调节肝脏的糖和脂代谢,并改善糖尿病。
Nat Med. 2013 Oct;19(10):1325-30. doi: 10.1038/nm.3294. Epub 2013 Sep 15.
8
Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis.肝脏神经酰胺可能在2型糖尿病和非酒精性脂肪性肝炎中介导脑胰岛素抵抗和神经退行性变。
J Alzheimers Dis. 2009;16(4):715-29. doi: 10.3233/JAD-2009-0984.
9
A liver Hif-2α-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition.肝脏 Hif-2α-Irs2 通路可增强肝胰岛素信号,且受 Vegf 抑制调节。
Nat Med. 2013 Oct;19(10):1331-1337. doi: 10.1038/nm.3295. Epub 2013 Sep 15.
10
Hypoxia-inducible factor-2α promotes fibrosis in non-alcoholic fatty liver disease by enhancing glutamine catabolism and inhibiting yes-associated protein phosphorylation in hepatic stellate cells.缺氧诱导因子-2α 通过增强肝星状细胞中的谷氨酰胺分解代谢和抑制 yes 相关蛋白磷酸化来促进非酒精性脂肪性肝病中的纤维化。
Front Endocrinol (Lausanne). 2024 Feb 28;15:1344971. doi: 10.3389/fendo.2024.1344971. eCollection 2024.

引用本文的文献

1
Plasma-activated water treatment delayed the lipid oxidation and degradation of golden pompano fillets during storage based on lipidomics.基于脂质组学分析,等离子体活化水处理延缓了黄金鲹鱼片在储存期间的脂质氧化和降解。
Food Chem X. 2025 Jul 16;29:102799. doi: 10.1016/j.fochx.2025.102799. eCollection 2025 Jul.
2
SOX9 Overexpression Ameliorates Metabolic Dysfunction-associated Steatohepatitis Through Activation of the AMPK Pathway.SOX9过表达通过激活AMPK通路改善代谢功能障碍相关脂肪性肝炎。
J Clin Transl Hepatol. 2025 Mar 28;13(3):189-199. doi: 10.14218/JCTH.2024.00197. Epub 2024 Dec 20.
3
Impact of Lipids on Insulin Resistance: Insights from Human and Animal Studies.
脂质对胰岛素抵抗的影响:来自人体和动物研究的新见解。
Drug Des Devel Ther. 2024 Jul 31;18:3337-3360. doi: 10.2147/DDDT.S468147. eCollection 2024.
4
Novel Insights into Psychosis and Antipsychotic Interventions: From Managing Symptoms to Improving Outcomes.精神分裂症及抗精神病药物干预的新视角:从症状管理到结局改善。
Int J Mol Sci. 2024 May 28;25(11):5904. doi: 10.3390/ijms25115904.
5
Ceramide in cerebrovascular diseases.脑血管疾病中的神经酰胺
Front Cell Neurosci. 2023 Jun 2;17:1191609. doi: 10.3389/fncel.2023.1191609. eCollection 2023.
6
Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism.小檗碱抗代谢综合征相关肾脏疾病的研究进展:关于作用及机制
Front Pharmacol. 2023 Feb 6;14:1112088. doi: 10.3389/fphar.2023.1112088. eCollection 2023.
7
A Review of and Its Component, Berberine, as an Antidiabetic and Antioxidant.关于小檗碱及其成分的综述,作为一种抗糖尿病和抗氧化剂。
Molecules. 2023 Jan 29;28(3):1294. doi: 10.3390/molecules28031294.
8
Berberine inhibits carcinogenesis through antagonizing the ATX-LPA-LPAR2-p38-leptin axis in a mouse hepatoma model.在小鼠肝癌模型中,小檗碱通过拮抗自噬相关蛋白6-溶血磷脂酸-溶血磷脂酸受体2-p38-瘦素轴抑制肿瘤发生。
Mol Ther Oncolytics. 2022 Aug 5;26:372-386. doi: 10.1016/j.omto.2022.08.001. eCollection 2022 Sep 15.